김병수 (서울대학교)님 | 한빛사연구자 > 한빛사

서울대학교

CV File

최종업데이트 2025.12.26.

Engineered extracellular vesicles reprogram T cells by targeting PD-1 and PHB1 signaling in inflammatory bowel disease
- Signal Transduct. Target. Ther., Dec 25 2025, 10 (1) | https://doi.org/10.1038/s41392-025-02516-0
- 2025-12
- 의약학
- 한빛사논문
Advances in mRNA-Lipid Nanoparticle Engineering for Immune Cell Targeting and Immune Modulation
- Small Methods, Sep 16 2025, | https://doi.org/10.1002/smtd.202501401
- 2025-09
- 바이오·의료융합
- 한빛사논문
Spatiotemporal control of neutrophil fate to tune inflammation and repair for myocardial infarction therapy
- Nat. Commun., 01 October 2024 | https://doi.org/10.1038/s41467-024-52812-6
- 2024-10
- 한빛사논문
Engineered Nanoparticles for Enhanced Antitumoral Synergy Between Macrophages and T Cells in the Tumor Microenvironment
- Adv. Mater., Sep 10 2024, | https://doi.org/10.1002/adma.202410340
- 2024-09
- 바이오·의료융합
- 한빛사논문
Ceria-vesicle nanohybrid therapeutic for modulation of innate and adaptive immunity in a collagen-induced arthritis model
- Nat. Nanotechnol., 26 October 2023 | https://doi.org/10.1038/s41565-023-01523-y
- 2023-10
- 바이오·의료융합
- 한빛사논문
A personalized cancer nanovaccine that enhances T-cell responses and efficacy through dual interactions with dendritic cells and T cells
- Adv. Mater., 2023 Jul 29;e2303979 | https://doi.org/10.1002/adma.202303979
- 2023-07
- 바이오·의료융합
- 한빛사논문
A personalized cancer vaccine that induces synergistic innate and adaptive immune responses
- Adv. Mater., 2023 May 30;e2303080 | https://doi.org/10.1002/adma.202303080
- 2023-05
- 생명과학
- 한빛사논문
Senescent cancer cell-derived nanovesicle as a personalized therapeutic cancer vaccine
- Exp. Mol. Med., Published: 01 March 2023 | https://doi.org/10.1038/s12276-023-00951-z
- 2023-03
- 바이오·의료융합
- 한빛사논문
Iron Oxide Nanoparticle-Incorporated Mesenchymal Stem Cells for Alzheimer’s Disease Treatment
- Nano Lett., 2023 Jan 13 | https://doi.org/10.1021/acs.nanolett.2c03682
- 2023-01
- 바이오·의료융합
- 한빛사논문
Tolerogenic nanoparticles induce type II collagen-specific regulatory T cells and ameliorate osteoarthritis
- Sci. Adv., 2022 Nov 25;8(47):eabo5284 | doi: 10.1126/sciadv.abo5284
- 2022-11
- 바이오·의료융합
- 한빛사논문

연구자 ID

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기